Thatch, a San Francisco-based health benefits platform, announced on Tuesday that it has successfully secured $108 million in Series C funding, a milestone that officially propels the company to a $1 billion valuation. This significant capital infusion underscores a growing momentum in the transition from traditional group health insurance toward individualized, portable benefits models. The funding round was led by a powerhouse coalition of venture capital firms, including The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, with participation from strategic partners such as ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital, and Avid Ventures. To date, Thatch has raised a total of $192.5 million in equity funding, signaling robust investor confidence in the platform’s ability to disrupt the legacy healthcare financing landscape.
The Evolution of Employer-Sponsored Healthcare: From Group Plans to Individual Choice
For decades, the American healthcare system has been anchored by the employer-sponsored group insurance model, a relic of the post-World War II era when wage freezes led companies to offer health benefits to attract talent. While this system has provided coverage for millions, it has long been criticized for its "one-size-fits-all" approach, which often leaves employees with limited choices and employers with unpredictable, ever-rising premiums.
Thatch aims to dismantle this rigidity by leveraging Individual Coverage Health Reimbursement Arrangements (ICHRAs). Recently rebranded within some industry circles as CHOICE Arrangements, ICHRAs allow employers to move away from picking a single insurance carrier for their entire workforce. Instead, employers provide employees with tax-free funds—a "health budget"—which the employees then use to purchase their own individual health insurance plans on the open market.
This shift mirrors the transition seen in retirement planning decades ago, when the industry moved from defined-benefit pensions to defined-contribution 401(k) plans. Thatch provides the technological infrastructure to make this transition seamless, handling the complexities of tax compliance, payroll integration, and plan selection. Beyond insurance premiums, the platform allows employees to utilize their health budgets for a variety of out-of-pocket expenses, including high-demand treatments such as GLP-1 weight-loss medications and mental health therapy.
Strategic Growth and Market Penetration
The Series C funding comes on the heels of a period of explosive growth for Thatch. According to CEO Chris Ellis, the company has seen its revenue increase nearly sevenfold over the past twelve months. The platform is currently utilized by more than 5,000 employers across the United States, ranging from small businesses to major national franchises like Jersey Mike’s and Smoothie King.
The involvement of payroll giants like ADP and Paychex in this funding round is particularly noteworthy. By integrating directly with these human resources and payroll platforms, Thatch reduces the administrative burden on HR departments, which has traditionally been one of the primary barriers to adopting individualized health plans.
"The funding round will help Thatch build out the infrastructure behind individual health coverage at scale," Ellis stated. "Concretely, that’s three things: deepening our integrations with payroll and HR platforms like ADP and Gusto, expanding the ways employees can use their health budgets, and growing the team fast enough to keep up with employer demand. We’re now working with more than 5,000 employers, and the money is going toward making the switch from a traditional group plan to a health budget as seamless as possible."
Analyzing the Investor Perspective: The Retailization of Healthcare
The investment community views Thatch not merely as a benefits administrator, but as a catalyst for the "retailization" of healthcare. Jahanvi Sardana, a partner at Index Ventures, drew parallels between Thatch and other tech giants that redefined consumer expectations in their respective sectors.
"Every massive consumer market eventually gets rebuilt around the individual—Amazon did it for retail, Expedia for travel, Robinhood for investing. Thatch is doing it for healthcare," Sardana said in a statement. She further noted that the integration of artificial intelligence (AI) will play a pivotal role in the platform’s evolution. "With AI, the end state is bigger than shopping: an agent that knows you, holds your wallet and can find, book and pay for the right care. The magic is that you stop navigating healthcare and start being taken care of."
The participation of Eli Lilly and Company is also strategically significant. As the healthcare industry grapples with the high costs of innovative drugs like GLP-1s, Thatch’s model provides a mechanism for employers to support these treatments through defined budgets rather than navigating the complex formulary restrictions of traditional group plans.

The Rising Tide of ICHRA Adoption
The broader market for ICHRAs is experiencing a period of rapid acceleration. Data from the HRA Council indicates that the number of employers offering these arrangements is on a steep upward trajectory. According to recent reports, the number of employers utilizing ICHRAs grew from approximately 6,600 in early 2023 to more than 12,700 by 2024, nearly doubling in a single year.
Advocates of the ICHRA model argue that it addresses the fundamental flaws of the current system by providing:
- Budget Predictability for Employers: Instead of facing annual double-digit premium hikes, employers can set a fixed contribution amount.
- Portability for Employees: Employees can maintain their individual plans even if they switch jobs, provided they continue to pay the premiums.
- Personalization: A young, single employee and an older employee with a family have vastly different healthcare needs; ICHRAs allow each to select a plan that fits their specific profile.
Despite these advantages, the transition requires a sophisticated technological "middle layer" to manage the flow of funds and ensure compliance with Affordable Care Act (ACA) requirements. Thatch has positioned itself as the leading provider of this infrastructure.
A Philosophical Shift: From Patients to Customers
At the core of Thatch’s mission is a philosophical re-evaluation of the individual’s role in the healthcare ecosystem. Chris Ellis argues that the current system’s terminology reflects its systemic failures.
"Right now healthcare is the only industry that calls its customers ‘patients,’ a word that literally means someone who suffers and waits. That’s not an accident," Ellis declared. "When an employer picks your insurance for you, the people actually competing for your business are HR benefits consultants, not you. We think that’s backwards."
Ellis contends that by placing the purchasing power directly in the hands of the individual, the healthcare industry will be forced to improve its service and efficiency, much like the travel or telecommunications industries did when they shifted toward consumer-direct models. He pointed to LASIK surgery—one of the few medical procedures where costs have decreased while quality increased—as an example of what happens when individuals pay for care directly and providers must compete for their business.
Future Outlook and Challenges
While the $108 million funding round provides Thatch with significant "dry powder" to expand, the company faces the challenge of navigating a highly regulated and fragmented insurance market. The success of the ICHRA model depends heavily on the stability and competitiveness of the individual insurance markets in various states. In regions where the individual market is thin or premiums are excessively high, the "health budget" model may be less attractive than traditional group coverage.
However, the trend toward decentralization in healthcare appears to be gaining momentum. As remote work becomes more prevalent, employers are increasingly managing workforces spread across multiple states, making a single group plan nearly impossible to administer effectively. Thatch’s platform solves this geographical hurdle by allowing employees to buy plans local to their residence while the employer maintains a centralized funding system.
With its new unicorn valuation, Thatch is poised to accelerate its hiring and product development. The focus on AI integration suggests a future where the platform does more than just move money; it may eventually act as a personalized health concierge, helping users optimize their spending and navigate the complexities of medical billing.
As the 2025 and 2026 benefits cycles approach, the industry will be watching closely to see if Thatch can maintain its 7x growth rate. If the current trajectory holds, the "CHOICE Arrangement" could soon become the standard rather than the alternative, marking the most significant shift in American employer-sponsored benefits in over half a century.
